期刊文献+

丙型肝炎与非酒精性脂肪性肝病 被引量:6

下载PDF
导出
摘要 丙型病毒性肝炎和非酒精性脂肪性肝病(NAFLD)是两类临床常见的慢性肝病。虽然二者病因、发病机制不尽相同,但临床上二者常常合并发生、相互影响,为临床诊治带来困难。胰岛素抵抗(IR)在二者关系中发挥至关重要的桥梁作用,表现为丙型肝炎病毒(HCV)感染可以诱导IR发生,加重肝脂肪变性及NAFLD病情进展,反之,NAFLD合并HCV感染患者由于存在IR,亦会影响抗病毒治疗的疗效及预后,加速病毒性肝炎向终末期肝病进展。
出处 《实用肝脏病杂志》 CAS 2008年第4期269-272,共4页 Journal of Practical Hepatology
  • 相关文献

参考文献29

  • 1NEUSCHWANDER-TETRI BA, CALDWELL SH. Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference[J]. Hepatology, 2003,37(5 ) : 1202-1219.
  • 2BEDOGNI G,BELLENTANI S. Fatty liver:how frequent is it and why[J]. Ann Hepatol,2004,3(2):63-65.
  • 3范建高,朱军,李新建,李锐,戴菲,宋晓敏,陈兰,李锋,陈世耀.上海市成人脂肪肝患病率及其危险因素流行病学调查[J].中华肝脏病杂志,2005,13(2):83-88. 被引量:582
  • 4HUI JM,SUD A,FARRELL GC,et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression[J]. Gastroenterology, 2003,125 (6) : 1695-1704.
  • 5SHINTANI Y,FUJIE H,MIYOSHI H,et al. Hepatitis C virus infection and diabetes:direct involvement of the virus in the development of insulin resistance[J]. Gastroenterology, 2004, 126( 3 ) : 840-848.
  • 6NEUMAN MG,BENHAMOU JP,MALKIEWICZ IM,et al. Kinetics of serum cytokines reflects changes in the severity of chronic hepatitis C presenting minimal fibrosis[J]. J Viral Hepat, 2002,9(2) : 134-140.
  • 7AYTUG S,REICH D,SAPIRO LE,et al. Impaired IRS-1/PI3 -kinase signaling in patients with HCV:a mechanism for increased prevalence of type 2 diabetes [J]. Hepatology, 2003,38(6): 1384-1392.
  • 8DHINDSA G,BHATIA R,DHINDSA M,et al. Insulin resistance,insulin sensitization and inflammation in polycystic ovarian syndrome[J]. J Postgrad Med, 2004,50(2) : 140-144.
  • 9SJOHOLM A,NYSTR M T. Chronic inflammation can cause type 2 diabetes[J]. Lakartidningen,2004,101(19): 1716-1721.
  • 10KAMADA Y,TAMURA S,KISO S,et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin[J]. Gastroenterology, 2003,125 (6) : 1796-1807.

二级参考文献31

  • 1王英杰,王小红,王宇明,李梦东.慢性重型肝炎患者中性粒细胞超微结构的改变[J].新消化病学杂志,1996,4(8):452-453. 被引量:3
  • 2范建高 曾民德 等.上海市4009名机关职员脂肪肝流行病学调查[J].中华肝脏病杂志,1998,6(1):17-17.
  • 3Clark JM, Diehl AM. Defining nonalcoholic fatty liver disease: Implications for epidemiologic studies. Gastroenterology, 2003, 124:248-250.
  • 4Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease.Gastroenterology, 2002, 123: 1705-1725.
  • 5Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology, 2004, 39: 476-483.
  • 6Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med,2000, 132: 112-117.
  • 7Omagari K, Kadokawa Y, Masuda J, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol, 2002, 17:1098-1105.
  • 8沈靖,徐耀初,高瞻,钮菊英,沈洪兵,叶本法.HCV与HBV对HCC病因协同作用的流行病学研究[J].新消化病学杂志,1997,5(2):72-74. 被引量:7
  • 9李淑兰,马晓霞,荆晓江.医院用血液制品HCV污染情况的调查[J].新消化病学杂志,1997,5(2):94-95. 被引量:1
  • 10唐振亚,齐俊英,沈汉馨,杨东亮,郝连杰.干扰素治疗慢性丙型肝炎近期与远期疗效[J].新消化病学杂志,1997,5(2):104-105. 被引量:12

共引文献604

同被引文献58

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部